▶ Full Post Text
Oracle used to be one of the most dependable, boring stocks you could own. Enterprise databases, steady margins, reliable dividends. Then Larry Ellison went all-in on AI infrastructure, and the stock fell from $346 in September 2025 to $135, a 60% drawdown on a company that was worth $400 billion at its peak.
So is it a buying opportunity? Let's look at both sides honestly.
The bull case is real, on paper. Oracle holds $553 billion in remaining performance obligations - contracted future revenue. Analysts project revenue nearly doubling from $57 billion today to $130 billion by FY2028. At 18.7x forward earnings, it trades below its own historical average and well below the tech sector median of about 29x. A standard DCF spits out $300 intrinsic value, implying massive upside. Analyst consensus is Buy with a $285 price target, and Norges Bank opened a $4.3 billion position in Q4. These aren't nothing.
But the bull case is built entirely on analyst estimates. The revenue doubling requires a 40% CAGR over the forecast period. Oracle's actual 9-year historical revenue CAGR is 5%. You're being asked to believe the growth rate will be eight times its historical average, sustained for years, based on a backlog that hasn't yet converted to recognised revenue. The DCF looks compelling precisely because it uses those same projections. It's circular.
The balance sheet makes this harder to ignore. Oracle is carrying $104 billion in debt, a debt-to-equity ratio above 5x, and free cash flow that turned negative last year after averaging $12 billion annually for nearly a decade. Across 80 large-cap tech peers, Oracle sits in the bottom 5th percentile on leverage. No other major software company has stretched its balance sheet this far while simultaneously betting on a growth inflection.
On top of this, insiders, including the CEO, CFO, and multiple presidents, have sold more than $3 billion in shares over the past eight quarters. Purchases over the same period: roughly $1 million. The people with the clearest view of whether that backlog actually converts are not buying.
A stock down 60% is sometimes a mispriced opportunity. Sometimes it's the market doing the math correctly. When the valuation thesis, the DCF, and the analyst targets all rest on the same optimistic growth assumptions, while insiders exit and debt sits at historic extremes, that's not a value play despite the 60% drop.
This one looks like the market got it right.